Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 3, 2013, Pages 163-178

  Ahmed, Rana ^a   Mccaffery, Kirsten J ^b   Aslani, Parisa ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

AMBIVALENCE; ANOREXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD HEALTH CARE; DECISION MAKING; DRUG COST; DRUG SAFETY; EMPOWERMENT; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INFORMATION DISSEMINATION; MEDICAL DECISION MAKING; MENTAL HEALTH CARE; PARENT; PARENT COUNSELING; PARENTAL ATTITUDE; PARENTAL DECISION MAKING; PERSONAL EXPERIENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; QUALITATIVE ANALYSIS; REVIEW; SELF REPORT; SOCIAL STIGMA; SYSTEMATIC REVIEW; THEMATIC ANALYSIS; TRUST;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DECISION MAKING; DRUG COSTS; HUMANS; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; SOCIAL SUPPORT; STEREOTYPING;

EID: 84876700610     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0087     Document Type: Review

References (61)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 3rd ed. Washington, DC: American Psychiatric Association; 1980.
2. Barkley RA: Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. New York: Guildford Press; 1990.
3. Bennet DS, Power TJ, Rostain AL, Carr DE: Parent acceptability and feasibility of ADHD interventions: assessment, correlates and predictive validity. J Pediatr Psychol 21: 643-657, 1996.
4. Braaten EB, Rosén LA: Self-regulation of affect in attention deficithyperactivity disorder (ADHD) and non-ADHD boys: Differences in empathic responding. J Consult Clin Psychol 68: 313-321, 2000.
5. Brinkman WB, Sherman SN, Zmitrovich AR, Visscher MO, Crosby LE, Phelan KJ, Donovan EF: Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder. Pediatrics 124: 580-589, 2009.
6. Bussing R, Gary FA: Practice guidelines and parental ADHD treatment evaluations: Friends or foes? Harv Rev Psychiatry 9: 223-233, 2001.
7. Canadian Attention Deficit Hyperactivity Disorder Resource Alliance (CADDRA): Canadian ADHD Practice Guidelines, 3rd ed. , Toronto: CADDRA; 2011.
8. Charach A, Skyba A, Cook L, Antle BJ: Using stimulant medication for children with ADHD: What do parents say? A brief report. J Can Acad Child Adolesc Psychiatry 15: 75-83, 2006.
9. Coulter A, Entwistle V, Gilbert D. Sharing decisions with patients: Is the information good enough? BMJ 318: 318-322, 1999.
10. Coulter DL, Koester BS: Information needs of parents of children with epilepsy. J Dev Behav Pediatr 6: 334-338, 1985.
11. Culpepper L: Primary care treatment of attention-deficit/hyperactivity disorder. J Clin Psychiatry 67(Suppl. 8): 51-58, 2006.
12. Curatolo P, D'Agati E, Moavero R: The neurobiological basis of ADHD. Ital J Pediatr 36: 79, 2010.
13. Daley D: Attention deficit hyperactivity disorder: A review of the essential facts. Child Care Health Dev 32: 193-204, 2006.
14. Daley D, Birchwood J: ADHD and academic performance: Why does ADHD impact on academic performance and what can be done to support ADHD children in the classroom? Child Care Health Dev 36: 455-464, 2009.
15. Dixon-Woods M, Fitzpatrick R: Qualitative research in systematic reviews. BMJ 323: 765-766, 2001.
16. Dixon-Woods M, Fitzpatrick R. , Roberts K: Including qualitative research in systematic reviews: Opportunities and problems. J Eval Clin Pract 7: 125-133, 2001.
17. dosReis S, Barksdale CL, Sherman A, Maloney K, Charach A: Stigmatizing experiences of parents of children with a new diagnosis of ADHD. Psychiatr Serv 61: 811-816, 2010.
18. dosReis S, Mychailyszyn MP, Evans-Lacko SE, Beltran A, Riley AW, Myers MA: The meaning of attention-deficit/hyperactivity disorder medication and parents' initiation and continuity of treatment for their child. J Child Adolesc Psychopharmacol 19: 377-383, 2009.
19. dosReis S, Myers MA: Parental attitudes and involvement in psychopharmacological treatment for ADHD: A conceptual model. Int Rev Psychiatry 20: 135-141, 2008.
20. Eiraldi RB, Mazzuca LB, Clarke AT, Power TJ: Service utilization among ethnic minority children with ADHD: A model of help seeking behavior. Adm Policy Ment Health 33: 607-622, 2006.
21. Fiks AG, Hughes CC, Gafen A, Guevara JP, Barg FK: Contrasting parents' and pediatricians' perspectives on shared decision-making in ADHD. Pediatrics 127: e188-e196, 2011.
22. Frances A: The first draft of DSM-V. BMJ 340: 1168, 2010.
23. Furman L: What is attention-deficit/hyperactivity disorder (ADHD)? J Child Neurol 20: 994-1002, 2005.
24. Gaston CM, Mitchell G: Information giving and decision-making in patients with advanced cancer: a systematic review. Soc Sci Med 61: 2252-2264, 2005.
25. Greenhill LL, Abikoff HB, Arnold LE, Cantwell DP, Conners CK, Elliott G, Hechtman L, Hinshaw SP, Hoza B, Jensen PS, March JS, Newcorn J, Pelham WE, Severe JB, Swanson JM, Vitiello B, Wells K: Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiatry 35: 1304-1313, 1996.
26. Hansen DL, Hansen EH: Caught in a balancing act: Parents' dilemmas regarding their ADHD child's treatment with stimulant medication. Qual Health Res 16: 1267-1285, 2006.
27. Harden A, Garcia J, Oliver S, Rees R, Shepherd J, Brunton G, Oakley A: Applying systematic review methods to studies of people's views: An example from public health research. J Epidemiol Community Health 58: 794-800, 2004.
28. Jackson D, Peters K: Use of drug therapy in children with attention deficit hyperactivity disorder (ADHD): Maternal views and experiences. J Clin Nurs 17: 2725-2732, 2008.
29. Johnston C, Hommersen P, Seipp C: Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: Relations to child and parent characteristics. Behav Ther 39: 22-32, 2008.
30. Kaplan G, Newcorn JH: Pharmacotherapy for child and adolescent attention-deficit hyperactivity disorder. Pediatr Clin N Am 58: 99-120, 2011.
31. Knutson KC, O'Malley M: Adult attention-deficit/hyperactivity disorder: A survey of diagnosis and treatment practices. J Am Acad Nurse Pract 22, 593-601, 2009.
32. Leslie LK, Plemmons D, Monn A, Palinkas LA: Investigating ADHD treatment trajectories: Listening to families' stories about medication use. J Dev Behav Pediatr 28: 179-188, 2007.
33. Lien MT, Carlson JS, Hunter-Oehmke S, Knapp KA: A pilot investigation of teachers' perceptions of psychotropic drug use in schools. J Atten Disord 11: 172-178, 2007.
34. Marshal MP, Molina BSG: Antisocial behaviors moderate deviant peer pathway to substance use in children with ADHD. J Clin Child Adolesc Psychol 35: 216-226, 2006.
35. McGuinness TM: Helping parents decide on ADHD treatment for their children. J Psychosoc Nurs Ment Health Serv 46: 23-27, 2008.
36. McLeod JD, Pescosolido BA, Takeuchi DT, White TF: Public attitudes toward the use of psychiatric medications for children. J Health Soc Behav 45: 53-67, 2004.
37. Merkel RL: Safety of stimulant treatment in attention deficit hyperactivity disorder: Part II. Expert Opin Drug Saf 9: 917-935, 2010.
38. Merkel RL, Kuchibhalta A: Safety of stimulant treatment in attention deficit hyperactivity disorder: Part I. Expert Opin Drug Saf 8: 655-668, 2009.
39. Morrow RL, Garland J, Wright JM, Maclure M, Taylor S, Dormuth CR: Influence of relative age on diagnosis and treatment of attention-deficit/ hyperactivity disorder in children. CanMed Assoc J 184: 755-762, 2012.
40. Morton RL, Tong A, Howard K, Snelling P, Webster AC: The views of patients and carers in treatment decision making for chronic kidney disease: Systematic review and thematic synthesis of qualitative studies. BMJ 340: c112, 2010.
41. Moynihan R, Doust J, Henry D: Preventing overdiagnosis: how to stop harming the healthy. BMJ 344: e: 3502, 2012.
42. National Health and Medical Research Council: Clinical Practice Points on the Diagnosis, Assessment and Management of Attention Deficit Hyperactivity Disorder in Children and Adolescents. Commonwealth of Australia; Canberra: Australian Government, 2012.
43. Nigg J, Nikolas M, Burt SA: Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49: 863-873, 2010.
44. Olaniyan O, dosReis S, Garriett V, Mychailyszyn MP, Anixt J, Rowe PC, Cheng TL: Community perspectives of childhood behavioral problems and ADHD among African American parents. Ambul Pediatr 7: 226-231, 2007.
45. Parsons S, Harding G, Breen A, Foster N, Pincus T, Vogel S, Underwood M: The influence of patients' and primary care practitioners' beliefs and expectations about chronic musculoskeletal pain on the process of care: A systematic review of qualitative studies. Clin J Pain 23: 91-98, 2007.
46. Peters K, Jackson D: Mothers' experiences of parenting a child with attention deficit hyperactivity disorder. J Adv Nurs 65: 62-71, 2009.
47. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA: The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry 164: 942-948, 2007.
48. Richie J, Spencer L: Qualitative data analysis for applied policy research. In: Analyzing Qualitative Data. Edited by A. Bryman, R. G. Burgess. London: Routledge; 1994; pp. 173-194.
49. Rowles BM, Findling RL: Review of pharmacotherapy options for the treatment of attention-deficit/hyperactivity disorder (ADHD) and ADHD-like symptoms in children and adolescents with developmental disorders. Dev Disabil Res Rev 16: 273-282, 2010.
50. Salmeron PA: Childhood and adolescent attention-deficit hyperactivity disorder: Diagnosis, clinical practice guidelines and social implications. J Am Acad Nurse Pract 21: 488-497, 2008.
51. Sandelowski M, Trimble F, Woodard EK, Barroso J: From synthesis to script: Transforming qualitative research findings for use in practice. Qual Health Res 16: 1350-1370, 2006.
52. Sawyer MG, Whaites L, Rey JM, Hazell PL, Graetz BW, Baghurst P: Health related quality of life of children and adolescents with mental disorders. J Am Acad Child Adolesc Psychiatry 41: 530-537, 2002.
53. Sciberras E, Iyer S, Efron D, Green J: Information needs of parents of children with attention-deficit/hyperactivity disorder. Clin Pediatr 49: 150-157, 2010.
54. Singh I: Boys will be boys: Fathers' perspectives on ADHD symptoms, diagnosis and drug treatment. Harv Rev Psychiatry 11: 308-316, 2003.
55. Singer-Leshinsky S: Attention-deficit/hyperactivity disorder: Helping families to achieve success. JAAPA 24: 52-57, 2011.
56. Stiefel G, Besag FMC: Cardiovascular effects of methylphenidate, amphetamines and atomoxetine in the treatment of attention deficit hyperactivity disorder. Drug Saf 33: 821-842, 2010.
57. Subcommittee on Attention-Deficit/Hyperactivity Disorder, Steering Committee on Quality Improvement and Management, Wolraich M, Brown L, Brown RT, DuPaul G, Earls M, Feldman HM, Ganiats TG, Kaplanek B, Meyer B, Perrin J, Pierce K, Reiff M, Stein MT, Visser S. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 128: 1007-1022, 2011.
58. Taylor M, O'Donoghue T, Houghton S: To medicate or not to medicate? The decision-making process of Western Australian parents following their child's diagnosis with attention deficit hyperactivity disorder. Int J Disabil Dev Educ 53: 111-128, 2006.
59. Tong A, Sainsbury P, Craig J: Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. Int J Qual Health Care 19: 349-357, 2007.
60. Wolraich ML, Doffing MA: Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate. CNS Drugs 18: 243-250, 2004.
61. Zimmer L: Qualitative meta-synthesis: A question of dialoguing with texts. J Adv Nurs 53, 311-318, 2006.